Iranian researchers in "Iran in Transition", the article which was published in the April 2019 in International Journal of The Lancet, have broadly examined the health status in Iran over the past centuries up to now.
Although statistics show that Iran has an estimated cases of 15,000 liver failure annually, and more than 5,000 Iranians die every year due to this disease, but Dr. Reza Malekzadeh, the deputy health minister of Iran, says that the country has been able to overcome all shortcomings and difficult obstacles, and by accomplishing more than 6,000 successful liver transplants, it has achieved stunning records in saving the lives of many of the people who die from this disease in 25 years of struggle.
The trend of hypertension with 39% increase in mortality due to it, has become a major threat in Iran during the past 25 years. Meanwhile, Dr Malekzadeh, Director of the Digestive Diseases Research Institute (DDRI) announced that 6.5 million Iranians have hypertension and are unaware of their disease.
With studies of researchers at the Digestive Diseases Research Institute of Tehran University of Medical Sciences, SOVODAK tablet (a combination of Sofosbuvir and Daclatasvir) was developed and the treatment of all genotypes of hepatitis C became definitive and easy
The Head of the Digestive Diseases Research Institute at Tehran University of Medical Sciences reported the annual incidence of more than 10,000 new cases of gastric cancer in the country, as well as the ranking of the 30 provinces for the rate of the deadliest cancer in Iran, as part of the first announcement for the results from the population-based "Gastric Cancer Registry” in Iran